-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 3, Thermo Fisher Scientific, together with QIAGEN, the world's leading provider of molecular diagnostic and sample preparation technologies, announced that the boards of directors of both sides have unanimously voted to approve Thermo Fisher Scientific's proposal
As early as November 2019, Thermo Fisher Scientific reportedly had plans to acquire QIAGEN, and this news prompted QIAGEN's stock price to climb steadily
Now, the acquisition proposal has finally come to an end
Thierry Bernard, Interim CEO and Senior Vice President, Head of Molecular Diagnostics Business Areas at QIAGEN, said, "QIAGEN's vision is to improve lives through our unique Sample to Insight molecular testing solution, and the strategic partnership with Thermo Fisher Scientific will usher in a new era of hope and provide our employees with the opportunity
"We look forward to and welcome QIAGEN employees to Thermo Fisher Scientific and are excited